Market_Media_Hub

  The global biosensor market report declares that the market has a possibility of reaching a valuation of around USD 35,729.14 million by the end of 2025. This would occur with the market scoring a 9.7% CAGR during the forecast period (2019-2025). Market Research Future (MRFR), in their latest report also deciphered various dynamics that can trigger better growth possibilities. Among the major factors, technical advancement, better funding for research and development, developing healthcare infrastructure in several countries, and others can ensure a hike in the growth rate. It is also going to benefit from the rising registered cases of diabetes and other lifestyle-related diseases. But the regulations for the  biosensor market  are quite strict owing to which new products are finding it difficult to get a proper footing. Also, the reimbursement policies regarding this are not providing ample support to the market. Several companies in the global market for biosensors are launching s

  The global pathological microscopes market size is estimated to accrue USD 523.20 million by 2023, states Market Research Future (MRFR) in its latest report.  Increasing prevalence of various diseases is the primary driver of the market. High incidence of cancer, tuberculosis, and diabetes among adults and children has called for advanced diagnostic procedures which can detect the symptoms at an early stage. This is expected to bolster the demand of the  pathological microscopes market  among its end-users. The market can exhibit 4.50% CAGR over the forecast period (2018-2023). High purchase and maintenance costs of microscopes can pose a challenge to the market. In addition, unfavorable reimbursement schemes which cover only government-run diagnostic centers can restrain market growth. Automation of laboratories which includes devices that gel with advanced technologies such as augmented reality which expands the image size and resolution is likely to boost market demand.  Eminent n

  Liquid biopsy uses the qualitative and quantitative differences amid various biomarkers such as circulating tumor cells (CTC), cell-free DNA, methylated ctAD, miRNA in a patient's blood, and cell-free RNA fragments (rRNA). Although some of these markers are seen even under other circumstances, such as trauma, there is a quantitative variance in form, degree of fragmentation, concentration, and composition. Liquid biopsy is a collection and analysis of usually non-invasive liquid biological tissue for the diagnosis and monitoring of diseases. It is the direct clinical application of two developments in medical science, namely the sequencing of the human genome and the increasing sensitivity of detection techniques and assays. The global  liquid biopsy market  is expected to grow at a CAGR of 28% during the forecast period, 2015-2022, according to Market Research Future. The global liquid biopsy market is supported by various market giants with advanced product portfolio and innova

  Bone graft is used in spinal surgery, sports, trauma plastic and facial surgery. Besides it can be used for filling the voids during absence of bones and structural stability. It is a surgical method to replace a defected or missing bone using bone graft from the body of the patient, another person, animals or cadaver. Bone graft is also used to heal wounds, treat complex fracture and others. The global bone graft substitute market is expected to touch USD 5,031 million at a stellar 6.52% CAGR over the forecast period (2017-2027). Simply put, bone graft is an implantable material that helps in promoting bone healing, osseous reconstruction and bone formation owing to its osteoinductive, osteogenic and osteoconductive properties. There are many factors that is driving the growth of the  bone graft substitute market . Leading players profiled in the bone graft substitute market include  Institut Straumann AG, Zimmer Biomet, Stryker Corporation, Medtronic plc, Dentsply Sirona, BioHorizo

  Medical automation is an emerging branch of the medical sector that is tended to evolve continuously in the presence of the technological advancements. Increasing prevalence of chronic diseases like cancer, diabetes, and others followed by the growing pharmaceutical and biotechnology sector are the major drivers for the market growth during the forecast period, 2017-2023. The  medical automation market  to reach USD 78.50 Billion, is expected to grow at a CAGR of 9.7% during the forecast period. According to the Indian Brand Equity Foundation in 2017, the Indian biotech industry holds about 2% share of the global biotech industry. The biotechnology industry in India comprises of about 800 companies and is valued to be about USD 11.6 billion in 2017. The key players in the global medical automation market are  Koninklijke Philips N.V., Siemens AG, GENERAL ELECTRIC, Medtronic, Stryker, Danaher, Accuray Incorporated, and others. Get Sample Copy of Report @  https://www.marketresearchfut

  According to the World Health Organization (WHO), close to 17.7 million patients have died from cardiovascular diseases (CVDs). This can culminate in a spike in the demand for cardiovascular devices. Rise in cases of obesity can also act as a precursor to CVDs and spur market demand. Government efforts to reduce hospital acquired infections (HAIs) is expected to fuel market demand exponentially. It can result in the demand for diagnostic and monitoring devices. The global  cardiovascular application market  size can touch a value of USD 36,730.5 million by 2023. It can display a CAGR of 7.24% over the forecast period. Rising prevalence of cardiovascular diseases, the large vulnerable geriatric populace, and reimbursement policies are major drivers of the market. Koninklijke Philips NV, GENERAL ELECTRIC, Boston Scientific Corporation, Abbott, Stryker, Terumo Corporation, and Medtronic  are major players of the global cardiovascular application market. Acquisitions, novel product launc

  According to the American Cancer Society, close to 97,000 cases of colon cancer were detected in 2018. The large geriatric population and their inclination towards gastrointestinal cancer due to their old age can drive the demand for advanced diagnostic methods. The risk of appendicitis and colorectal cancer (CRC) in this particular demographic can influence the demand for endoscopic procedures. The global  capsule endoscopy market  is expected to touch USD 967.4 million by 2023. It can exhibit a CAGR of 8.82% from 2018 to 2023. Major factors driving market growth include the large geriatric population and high prevalence of small intestinal disorders. RF Co. Ltd, Olympus Corporation, Fujifilm Holding Corporation, IntroMedic, Chongqing Jinshan Science & Technology, Medtronic PLC, AccuRead Endoscopy Inc., and CapsoVision Inc . are prominent players of the global capsule endoscopy market. Expansions, acquisitions, product development, and new technological breakthroughs are strateg

  The global  Theranostics Market Growth  accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period. Theranostics is a new field of medicine which combines therapeutics, nanoscience, and diagnostics based on specific targeted diagnostic tests. Few of the prominent players in the global theranostics market are  Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Focus Diagnostics, Abbott Laboratories, Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Myriad Genetics, Inc., Foundation Medicine, Inc., and Ameri Path, Inc.  Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases.  Theranostics is also called as the ragnostics or companion diagnostics (CDx), or pharmacodiagnostics or persona

  The global Medical Digital Imaging Devices Market Size is likely to grow at a 7.1% CAGR between 2019- 2024, reveals the new Market Research Future (MRFR) report.  Medical digital imaging devices , simply put, are devices utilized to image the human body for obtaining a correct diagnosis and determining future care. Nuclear imaging, MRI, ultrasound, computed tomography, and x-ray are the different types of medical digital imaging devices. Leading players profiled in the global medical digital imaging devices market report include  Shimadzu, Hitachi, Hologic, Canon Medical Systems Corporation, Esaote SPA, Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V. Various factors are adding to the medical imaging equipment market share. Such factors, as revealed by the latest MRFR report, include an increase in diagnostic imaging centers, growing investments by the government for modernization of imaging facilities, technological advances in imaging systems, and burgeoning demand

  In the recent years,  cardiovascular information systems market  have undergone a transformation to meet demands for better interoperability, changing healthcare IT landscape and infrastructure and need to meet healthcare reform requirements. Various market players are either undertaking collaborative efforts or launching new products and therefore aiding in the growth of the cardiovascular information systems industry. Some of the major cardiovascular information systems market players include  General Electric Company, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, McKesson Corporation, Cerner Corporation, IBM Health, LUMEDX, Agfa-Gevaert N.V., Digisonics Inc., Carestream Health, Epic Systems Corporation, Scimage, Inc. and others. According to the WHO, cardiovascular diseases are one of the leading causes for deaths around the world. With rising incidence of cardiovascular diseases and demand for consolidation of medical records, cardiovascular infor